Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

AbbVie Inc. (ABBV)

86.98   0.26 (0.3%) 12-06 16:02
Open: 87.21 Pre. Close: 86.72
High: 87.71 Low: 86.78
Volume: 6,045,168 Market Cap: 128628M
AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 87.786 - 88.405 88.405 - 88.885
Low: 85.608 - 86.273 86.273 - 86.789
Close: 86.125 - 87.139 87.139 - 87.925

Technical analysis

as of: 2019-12-06 4:32:15 PM
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 105.60     One year: 123.34
Support: Support1: 83.44    Support2: 79.13
Resistance: Resistance1: 90.41    Resistance2: 105.60
Pivot: 87.44
Moving Average: MA(5): 86.78     MA(20): 87.16
MA(100): 74.23     MA(250): 77.77
MACD: MACD(12,26): 1.72     Signal(9): 2.25
Stochastic oscillator: %K(14,3): 32.48     %D(3): 30.27
RSI: RSI(14): 59.90
52-week: High: 92.99  Low: 62.66  Change(%): -0.7
Average Vol(K): 3-Month: 759472  10-Days: 662505

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
ABBV has closed above bottom band by 37.5%. Bollinger Bands are 44.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to ABBV's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Worldwide Chronic Disease Management Industry Insights, 2018-2024: Emphasis on Advance Needle-Free Drug Delivery Technologies, Diagnostic Methods, and Smart Device Technologies
DUBLIN , Dec. 6, 2019 /PRNewswire/ -- The "Chronic Disease Management: Therapeutics, Device Technologies and Global Markets" report has been added to's offering. This report is an analytical business tool with the primary purpose of providing a thorough evaluation of the global market for chronic disease management through various therapeutics and advanced device technologies. Report Scope Brief outline of the global markets and therapeutic device technologies for chronic disease management Analyses of global market trends with data from 2018, estimates for 2019, and projections of compound annual growth rates (CAGRs) through 2024 Key insight into the current state of chronic diseases and disorders, with an emphasis on advance needle-free drug delivery technologies, diagnostic methods, and smart device technologies that support effective disease state management Data corresponding to global chronic disease management markets by disease type that includes various chronic diseases, therapeutic drugs, treatment adherence devices & systems, drug delivery technologies, and treatment & management providers Regulatory structure for pharmaceuticals and medical devices, pricing and reimbursement structure, marketed and pipeline products, and major developments influencing the market Detailed company profiles and competitive landscape of major market players, including Roche, AbbVie, Johnson & Johnson, Bristol-Myers Squibb, Merck and GlaxoSmithKline Market Insights This market growth is fueled by a growing geriatric population, changing lifestyle, increasing prevalence of chronic diseases, superior clinical results of new drugs and biologics, increasing trend of digital health, the U.S.

Allergan : Form 8.3 - Abbvie Inc | MarketScreener

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  New York Stock Exchange
Sector:  Healthcare
Industry:  Drug Manufacturers - Major
Shares Out. (M) 1480.00
Shares Float (M) 1480.00
% Held by Insiders 0.09
% Held by Institutions 71.89
Shares Short (K) 60800
Shares Short P. Month (K)

Stock Financials

EPS 2.180
Book Value (p.s.) -5.560
PEG Ratio 2.88
Profit Margin 9.90
Operating Margin 41.11
Return on Assets (ttm) 13.4
Return on Equity (ttm)
Qtrly Rev. Growth 3.0
Gross Profit (p.s.) 16.919
Sales Per Share
EBITDA (p.s.) 10.446
Qtrly Earnings Growth -31.40
Operating Cash Flow (M) 13440.00
Levered Free Cash Flow (M) 10290.00

Stock Valuations

P/E 39.90
P/E Growth Ratio
P/BV -15.64
P/S 3.92
P/CF 9.58

Dividends & Splits

Dividend 4.280
Dividend Yield 0.05
Dividend Pay Date 2020-02-14
Ex-Dividend Date 2020-01-14
Forward Dividend 4.720
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.